The Trump administration is reported by German paper, to have offered German mRNA vaccine manufacturer CureVac 1 billion euros to secure their work exclusively for the US. [1, 2, 3]
Richard Grenell, the US ambassador to Germany and the acting director of national intelligence, tweeted that the Welt am Sonntag report was “not true.”
CureVac has partnered with GlaxoSmithKline and began development of mRNA-based COVID-19 vaccine candidates in January 2020.
The Gates Foundation is the second biggest shareholder of CureVac, the largest is a software tycoon, Dietmar Hopp!